2269 fundamentals
WUXI BIOLOGICS (CAYMAN) INC financial statements, including revenue, expenses, profit, and loss
The total revenue of 2269 for the last semiannual is 9.29 B HKD, and it's 0.68% higher compared to the previous semiannual. The net income of H1 24 is 1.62 B HKD.
0.00
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: HKD
TTM